As Congress appears headed to shut down the grimy business of intoxicating hemp any day now, the critical question going forward is how much the legitimate market for CBD tinctures, health aids and cosmetics will be affected.
The shady, greedy producers of intoxicating hemp have so thoroughly blurred the definition of “hemp” that Congress is now poised to regulate all hemp-derived cannabinoids as if they were interchangeable.
By pushing delta-8, THCA flower and other synthetic THC variants into gas stations and vape shops under the banner of “hemp,” the intoxicating-hemp sector erased the distinction between psychoactive products and mainstream CBD — and now a federal crackdown aimed at one may affect the other.
A hemp provision tucked inside the broader government funding package was passed by the Senate Monday evening after senators cleared the bill for consideration on Sunday. The Senate voted 76–24 to kill Rand Paul’s amendment that would have removed the hemp language, leaving the restriction intact.
If passed by the House of Representatives and signed into law, the provision would rewrite the 2018 Farm Bill definition of hemp by imposing a total THC limit of 0.4 milligrams per package for any product intended for human or animal use — a standard that would effectively wipe out delta-8, THCA flower and other intoxicating hemp products now sold at retail. The White House told NBC News that Donald Trump “supports the current language in the bill on hemp” that would ban the hemp intoxicants.
The risk to CBD
With the language expected to eliminate intoxicating hemp altogether, the essential question is no longer whether or when the measure will pass. It is what will happen to regular CBD — the lawful, non-intoxicating products people use for sleep, anxiety and pain. Are those products suddenly in the same line of fire as gas-station THC gummies?
Congress is moving to shut down intoxicating hemp by redefining hemp for consumer products and imposing a total THC limit of just 0.4 milligrams per package. That threshold ends the intoxicating-hemp market, because nearly every delta-8 or THCA product exceeds it.
But the language is broad enough that full-spectrum CBD products — legal under the 2018 Farm Bill and sold through mainstream retailers — may also be swept up simply because they contain natural trace THC.
How we got here
The potential collateral damage is real, and it was manufactured by the intoxicating-hemp industry itself. Instead of acknowledging that lab-made intoxicants were effectively THC and belonged in regulated cannabis channels, delta-8 operators argued — loudly and publicly — that anything produced from hemp should be treated as hemp.
They used CBD’s credibility to sell intoxicants. They used the word “hemp” as a loophole. Now, when Congress looks at hemp, it sees a runaway THC market and reaches for a blunt regulatory instrument. CBD, through no fault of its own, gets pulled into the sweep.
For years, responsible CBD companies pleaded for rules: testing standards, labeling requirements, and age restrictions. Those efforts were drowned out by operators who wanted the opposite and who found allies in the U.S. Hemp Roundtable, which pushed the position that intoxicating THC products were part of the same hemp industry as CBD.
The delta-8 market exploded by design. Cheap CBD isolate could be converted into THC isomers and sold outside state cannabis systems. These products were packaged like candy and marketed online to minors. The result is that Congress now views the entire hemp-derived cannabinoids category as untrustworthy — including CBD.
Kentucky vs. Kentucky
The Senate dispute would be farcical if the consequences weren’t so serious. Sen. Paul fears the imminent legislation will “destroy the hemp industry.” Fellow Kentuckian Sen. Mitch McConnell, who wrote hemp legalization into the 2018 Farm Bill, now calls the intoxicating-hemp market an unintended outcome of his own 2018 legislation. They are fighting over what “hemp” means. Neither is talking about CBD as consumers understand it.
The measure will pass. The intoxicating-hemp loophole will close. What matters is whether CBD can escape the shadow cast by an industry that used its name, borrowed its legitimacy and now threatens its future.